Delivery Order SPE2DB22D1202-SPE2DB26FUEV7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,715.38 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count) on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,254.01 for Veozah 45 mg tablets (30-count units) on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price contract represents a non-competitive set-aside procurement for pharmaceutical supply to support federal medical needs. The award was fulfilled by AmerisourceBergen's Corporate Office division, with performance conducted at the company's Conshohocken,...
- The Defense Logistics Agency awarded a $3,079.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-unit supply) on August 14, 2025, with an ultimate completion date of August 15, 2025. This non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count units) with a ceiling value of $17,319.74. This firm fixed-price delivery order, awarded on July 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,414.80 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count packages). This firm fixed-price, non-set-aside delivery order was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued under a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count packaging) valued at $6,334.82 under a firm fixed-price contract. The award was issued on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a non-competitive set-aside delivery against the company's larger indefinite delivery contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its...
- The Defense Logistics Agency awarded a delivery order valued at $3,872.10 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30 count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and operates as a child...
- The Defense Logistics Agency awarded a delivery order valued at $16,183.30 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units). The award was made on September 8, 2025, with an ultimate completion date of September 9, 2025, under firm fixed price terms with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Veozah 45 mg tablets (30-count units) under a firm fixed-price contract valued at $13,060.20. This delivery order, which is not set-aside for any socioeconomic category, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 billion through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.24 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB26FUEV7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,930.10 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count units) on October 14, 2025, with an ultimate completion date of October 15, 2025. This firm fixed-price, competitively awarded delivery order represents fulfillment under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. No set-aside designation was used for this award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, serves as a critical federal medical procurement vendor for military and veteran healthcare systems through its comprehensive pharmaceutical supply portfolio. This delivery order for Veozah, a branded pharmaceutical product, exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems with specialty medications and branded drugs. The broader SPE2DX contract demonstrates AmerisourceBergen's capacity to supply a vast range of pharmaceutical products, medical supplies, vaccines, and related commodities across multiple therapeutic domains to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 10/14/25 |